SS31 Peptide: A Revolutionary Mitochondrial-Targeting Therapeutic Agent
Introduction The SS31 peptide, also known as elamipretide, has emerged as a promising therapeutic agent targeting mitochondrial dysfunction, a key factor in aging, neurodegenerative diseases, […]